Suchergebnisse - "Denosumab"

PubPharm (5.449)

1

Assessing EGFR-mutated NSCLC with bone metastasis : Clinical features and optimal treatment strategy

enthalten in: Cancer medicine | 2024

von Chen, W. | Cheng, W. | Chen, C. | +6

2

Cancer risk in patients treated with denosumab compared with alendronate : A population-based cohort study

enthalten in: Bone | 2024

von Yahyavi, S. | Holt, R. | Knudsen, N. | +10

3

Denosumab-induced bone changes in a child : a case report

enthalten in: Pediatric radiology | 2024

von Rutten, C. | Martinez-Rios, C. | Daneman, A.

4

Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents : A Global Expert Guidance Document

enthalten in: The Journal of clinical endocrinology and metabolism | 2024

von Vanderniet, J. | Szymczuk, V. | Högler, W. | +7

5

Equivalence trial of proposed denosumab biosimilar GP2411 and reference denosumab in postmenopausal osteoporosis : the ROSALIA study

enthalten in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research | 2024

von Jeka, S. | Dokoupilová, E. | Kivitz, A. | +9

6

Three-year follow-up of a novel orthopedic ward fracture liaison services (OWFLS) model

enthalten in: The Journal of international medical research | 2024

von Cai, X. | Ying, Y. | Zhang, C. | +3

7

Medication-Related Osteonecrosis of the Jaw : evaluation of a therapeutic strategy in oral surgery

enthalten in: Journal of stomatology, oral and maxillofacial surgery | 2024

von Natu, M. | Meuric, V. | Roginski, P. | +2

8

Five-Year Outcomes of Continuous Treatment with Zoledronic Acid Versus Denosumab in Older Men with High Fracture Risk : Risk Factor Analysis of Bone Density Improvement and Incidence of New Fracture

enthalten in: Journal of clinical pharmacology | 2024

von Wu, T. | Tsou, Y. | Wu, W. | +3

9

Recognizing bisphosphonate-induced ear osteonecrosis in primary care : a case report

enthalten in: Family practice | 2024

von Mayer, A. | Oladokun, D. | Mistry, D.

10

Effect of denosumab on inflammation and bone health in active Charcot foot : A phase II randomised controlled trial

enthalten in: Journal of diabetes and its complications | 2024

von Lasschuit, J. | Center, J. | Greenfield, J. | +2

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[545]